Phenogenetics of Liability to Substance Use Disorders
物质使用障碍的表观遗传学
基本信息
- 批准号:7111806
- 负责人:
- 金额:$ 12.26万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2005
- 资助国家:美国
- 起止时间:2005-08-15 至 2010-07-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (provided by applicant):
Variation in the risk for abuse of and dependence on illicit substances (substance use disorders, SUD) is determined by multiple genetic and environmental factors. The etiology and pathogenesis of these complex disorders involve many facets of biological function (e.g., biochemical, physiological, behavioral, etc.), effects of abusable drugs on brain neurochemistry, and multiple environmental influences, and unfold throughout the life. Contribution of and interactions between these systems at the genetic level, as well as with environmental factors, need to be taken into account in research to comprehensively explicate SUD.
The overarching aim of this Independent Scientist Award (K02) application is to integrate neurobiological, genetic, psychological and environmental information to elucidate the individual trajectory to SUD. Emphasis is placed on improving understanding of the relation between genetic and neurobiological processes as components of individual liability. To achieve this goal, expertise will be acquired in the developmental neurobiology of SUD that can be integrated with advanced genetic analysis of complex traits. Research will thus focus on empirically-based selection of genes within candidate neurobiological systems, and analysis of their association with the risk for SUD using quantitative trait indices of liability.
To conduct this interdisciplinary research, I will access the consolidated database of Center for Education on Drug Abuse Research's (CEDAR; P50DA005605) and its genetic grogram, R01DA019157 "Substance Use Disorder Liability: Candidate Gene Systems" (CGS) consisting of multidisciplinary family data encompassing genetic, biochemical, psychological, psychiatric and environmental factors prospectively in target children at ages 10-12, 16, 19, and 22. The applicant is the Center's Co-Pi and Scientific Director as well as PI of the CGS project.
描述(由申请人提供):
滥用滥用风险和对非法物质的依赖(物质使用障碍,SUD)的变化是由多种遗传和环境因素决定的。这些复杂疾病的病因和发病机理涉及生物功能的许多方面(例如,生化,生理,行为等),可滥用药物对脑神经化学的影响以及多种环境影响,以及在整个生活中展开。这些系统在遗传水平以及与环境因素之间的贡献和相互作用需要在研究中考虑到全面解释SUD。
该独立科学家奖(K02)应用的总体目的是整合神经生物学,遗传,心理和环境信息,以阐明SUD的个体轨迹。重点是提高人们对遗传和神经生物学过程之间关系的理解,这是个人责任的组成部分。为了实现这一目标,将在SUD的发育神经生物学中获得专业知识,这些神经生物学可以与复杂性状的先进遗传分析集成在一起。因此,研究将集中于候选神经生物学系统中基于经验的基因选择,并分析其与使用责任定量性状指数的相关性。
To conduct this interdisciplinary research, I will access the consolidated database of Center for Education on Drug Abuse Research's (CEDAR; P50DA005605) and its genetic grogram, R01DA019157 "Substance Use Disorder Liability: Candidate Gene Systems" (CGS) consisting of multidisciplinary family data encompassing genetic, biochemical, psychological, psychiatric and environmental factors prospectively在10-12、16、19和22岁的目标儿童中。申请人是该中心的Co-PI和科学主任以及CGS项目的PI。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MICHAEL M VANYUKOV其他文献
MICHAEL M VANYUKOV的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MICHAEL M VANYUKOV', 18)}}的其他基金
Phenogenetics of Liability to Substance Use Disorders
物质使用障碍的表观遗传学
- 批准号:
6987618 - 财政年份:2005
- 资助金额:
$ 12.26万 - 项目类别:
Phenogenetics of Liability to Substance Use Disorders
物质使用障碍的表观遗传学
- 批准号:
7480206 - 财政年份:2005
- 资助金额:
$ 12.26万 - 项目类别:
Phenogenetics of Liability to Substance Use Disorders
物质使用障碍的表观遗传学
- 批准号:
7667810 - 财政年份:2005
- 资助金额:
$ 12.26万 - 项目类别:
Phenogenetics of Liability to Substance Use Disorders
物质使用障碍的表观遗传学
- 批准号:
7271286 - 财政年份:2005
- 资助金额:
$ 12.26万 - 项目类别:
Substance Use Disorder Liability: Candidate Gene System
物质使用障碍责任:候选基因系统
- 批准号:
6954090 - 财政年份:2004
- 资助金额:
$ 12.26万 - 项目类别:
Substance Use Disorder Liability: Candidate Gene System
药物使用障碍责任:候选基因系统
- 批准号:
7277201 - 财政年份:2004
- 资助金额:
$ 12.26万 - 项目类别:
Substance Use Disorder Liability: Candidate Gene System
物质使用障碍责任:候选基因系统
- 批准号:
7115913 - 财政年份:2004
- 资助金额:
$ 12.26万 - 项目类别:
Substance Use Disorder Liability: Candidate Gene System
物质使用障碍责任:候选基因系统
- 批准号:
7480205 - 财政年份:2004
- 资助金额:
$ 12.26万 - 项目类别:
相似国自然基金
老年重症新冠患者体内炎性细胞的特点、免疫致病机制及临床转归的研究
- 批准号:82370019
- 批准年份:2023
- 资助金额:65 万元
- 项目类别:面上项目
MUC5B/Siglec途径对RA-ILD巨噬细胞胞葬的作用机制及临床价值研究
- 批准号:82302605
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
AD谱系患者视网膜标记物偶联视觉神经环路的调控机制及其临床应用研究
- 批准号:82371437
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
结外鼻型NK/T细胞淋巴瘤免疫特征分析与临床转化研究
- 批准号:82370199
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
基于基因组-蛋白质组解析煤烟型肺癌分子特征及临床分群的研究
- 批准号:82360613
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
相似海外基金
The role of remission in the intergenerational transmission of alcohol use disorder: Course, context, and offspring outcomes
缓解在酒精使用障碍代际传播中的作用:病程、背景和后代结果
- 批准号:
10736096 - 财政年份:2023
- 资助金额:
$ 12.26万 - 项目类别:
8th International RASopathies Symposium: Expanding Research and Care Practice through Global Collaboration and Advocacy
第八届国际 RASopathies 研讨会:通过全球合作和宣传扩大研究和护理实践
- 批准号:
10683644 - 财政年份:2023
- 资助金额:
$ 12.26万 - 项目类别:
Genetic architecture of transdiagnostic psychosis symptom dimensions
跨诊断精神病症状维度的遗传结构
- 批准号:
10572178 - 财政年份:2023
- 资助金额:
$ 12.26万 - 项目类别:
Development and Initial Testing of a Behavioral Intervention to Increase Pre-Test Genetic Counseling Among Families at Risk of Lynch Syndrome
行为干预的开发和初步测试,以增加有林奇综合症风险的家庭的测试前遗传咨询
- 批准号:
10581154 - 财政年份:2023
- 资助金额:
$ 12.26万 - 项目类别:
Clinical and Nutrigenetic Assessment of Zinc in Patients with Prediabetes
糖尿病前期患者锌的临床和营养遗传学评估
- 批准号:
10713103 - 财政年份:2023
- 资助金额:
$ 12.26万 - 项目类别: